User profiles for Houriiyah Tegally
 | Houriiyah TegallyUniversity of KwaZulu-Natal (UKZN), KwaZulu-Natal Research, Innovation & Sequencing … Verified email at stu.ukzn.ac.za Cited by 13424 |
[HTML][HTML] Detection of a SARS-CoV-2 variant of concern in South Africa
Continued uncontrolled transmission of SARS-CoV-2 in many parts of the world is creating
conditions for substantial evolutionary changes to the virus 1 , 2 . Here we describe a newly …
conditions for substantial evolutionary changes to the virus 1 , 2 . Here we describe a newly …
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
The progression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…
Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
Continued uncontrolled transmission of the severe acute respiratory syndrome-related
coronavirus 2 (SARS-CoV-2) in many parts of the world is creating the conditions for significant …
coronavirus 2 (SARS-CoV-2) in many parts of the world is creating the conditions for significant …
[HTML][HTML] Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B.1.1.529),
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …
[HTML][HTML] Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
The SARS-CoV-2 epidemic in southern Africa has been characterized by three distinct waves.
The first was associated with a mix of SARS-CoV-2 lineages, while the second and third …
The first was associated with a mix of SARS-CoV-2 lineages, while the second and third …
[HTML][HTML] Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant
…, L Rossouw, C Taoushanis, H Tegally… - … England Journal of …, 2021 - Mass Medical Soc
Background Assessment of the safety and efficacy of vaccines against the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …
[HTML][HTML] Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa
Three lineages (BA.1, BA.2 and BA.3) of the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) Omicron variant of concern predominantly drove South Africa’s fourth …
2 (SARS-CoV-2) Omicron variant of concern predominantly drove South Africa’s fourth …
[HTML][HTML] T cell responses to SARS-CoV-2 spike cross-recognize Omicron
The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations 1 , 2 that
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
[HTML][HTML] Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma
SARS-CoV-2 variants of concern (VOC) have arisen independently at multiple locations 1 ,
2 and may reduce the efficacy of current vaccines that target the spike glycoprotein of SARS-…
2 and may reduce the efficacy of current vaccines that target the spike glycoprotein of SARS-…
[HTML][HTML] Omicron BA. 4/BA. 5 escape neutralizing immunity elicited by BA. 1 infection
SARS-CoV-2 Omicron (B.1.1.529) BA.4 and BA.5 sub-lineages, first detected in South Africa,
have changes relative to Omicron BA.1 including substitutions in the spike receptor binding …
have changes relative to Omicron BA.1 including substitutions in the spike receptor binding …